FCX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Freeport-McMoRan Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Firm – FCX

NEW YORK CITY, NY / ACCESS Newswire / December 16, 2025 / WHY: New York, N.Y., December 16, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Freeport-McMoRan Inc. (NYSE:FCX) between February 15, 2022 and September 24, 2025, both dates inclusive (the "Class Period"), of the important January 12, […]

First Community Bankshares, Inc. Announces Special Dividend

(NASDAQ:FCBC), BLUEFIELD, Va., Dec. 16, 2025 (GLOBE NEWSWIRE) — First Community Bankshares, Inc. (NASDAQ: FCBC) (www.firstcommunitybank.com) (the “Company”) today reported its Board of Directors declared a special cash dividend to common shareholders of $1.00 per common share. The Company's capital management plan and philosophy require the maintenance of a strong capital base from which to

First Community Bankshares, Inc. Announces Special Dividend

First Community Bankshares, Inc. Announces Special Dividend GlobeNewswire December 16, 2025 BLUEFIELD, Va., Dec. 16, 2025 (GLOBE NEWSWIRE) — First Community Bankshares, Inc. (NASDAQ: FCBC) (www.firstcommunitybank.com) (the “Company”) today reported its Board of Directors declared a special cash dividend to common shareholders of $1.00 per common share. The Company's capital management plan and philosophy require

Steelworkers union pleased with the approval of Anglo-Teck transaction

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) — United Steelworkers union District 3 Director Scott Lunny issued the following statement in response to the federal government's approval of the Anglo-Teck transaction, including undertakings related to investment in Canada, job protection, and job creation: “Today's decision provides important clarity for Steelworkers and their families, and

Steelworkers union pleased with the approval of Anglo-Teck transaction

Steelworkers union pleased with the approval of Anglo-Teck transaction GlobeNewswire December 16, 2025 VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) — United Steelworkers union District 3 Director Scott Lunny issued the following statement in response to the federal government's approval of the Anglo-Teck transaction, including undertakings related to investment in Canada, job protection, and

Investor Notice: Robbins LLP Informs Investors of Gauzy Ltd. Securities Class Action

Robbins LLPinforms stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gauzy Ltd. (NASDAQ: GAUZ) securities between March 11, 2025 and November 13, 2025. Gauzy develops, manufactures, and supplies vision and light control technology products. https://mma.prnewswire.com/media/1321386/Robbins_LLP_Logo.jpg For more information, submit a form, emailattorney Aaron Dumas, Jr., or

JHX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX

NEW YORK CITY, NY / ACCESS Newswire / December 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of James Hardie Industries plc (NYSE:JHX) between May 20, 2025 through August 18, 2025, both dates inclusive (the "Class Period") of the important December 23, 2025 lead plaintiff

Riley Permian Announces New Share Repurchase Program

Riley Exploration Permian, Inc. (NYSEAmerican: REPX) (“Riley Permian”) today announced that the Board of Directors has authorized the initiation of a share repurchase program of up to $100 million of the currently outstanding shares of the Company's common stock over a period of 24 months. The Board also authorized the Company to enter into written

The Next Chapter in Obesity Therapeutics: Vial’s INHBE siRNA Draws KOL Praise as a Next-Generation Obesity Therapy

EXECUTIVE SUMMARY — Vial's INHBE siRNA is a first-in-class, liver-targeted (GalNAc-conjugated) siRNA therapy that silences INHBE and its gene product, ActivinE — Leading key opinion leaders (KOLs) Drs. Jason Fung, Scott Kahan, Lawrence Cheskin, and Lee Kaplan from leading institutions such as Johns Hopkins, GMU, and Dartmouth University respectively shared their insights on challenges with

BetterWay Blood Testing by Babson Diagnostics Achieves SOC 2 Compliance

AUSTIN, TX / ACCESS Newswire / December 16, 2025 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today that it has achieved SOC 2 type I compliance through a third-party audit of its information security and privacy controls. Compliance with SOC 2’s high standards reflects Babson

Scroll to Top